HIV‐1 Tat Peptide‐Gemcitabine Gold (III)‐PEGylated Complex—Nanoflowers: A Sleek Thermosensitive Hybrid Nanocarrier as Prospective Anticancer

[1]  P. Saftig,et al.  At the acidic edge: emerging functions for lysosomal membrane proteins. , 2003, Trends in cell biology.

[2]  S. Rajeshkumar,et al.  Optimization and stabilization of gold nanoparticles by using herbal plant extract with microwave heating , 2014, Nano Convergence.

[3]  R. Sahu,et al.  Natural Anti-Cancer Agents: Implications in Gemcitabine-Resistant Pancreatic Cancer Treatment. , 2017, Mini reviews in medicinal chemistry.

[4]  Nadia Djaker,et al.  Polyphosphonate ligands: From synthesis to design of hybrid PEGylated nanoparticles toward phototherapy studies. , 2018, Journal of colloid and interface science.

[5]  Jolanda Spadavecchia,et al.  One-step synthesis of collagen hybrid gold nanoparticles and formation on Egyptian-like gold-plated archaeological ivory. , 2014, Angewandte Chemie.

[6]  Takuma Sasaki,et al.  Influence of Cytidine Deaminase on Antitumor Activity of 2′-Deoxycytidine Analogs In Vitro and In Vivo , 2010, Drug Metabolism and Disposition.

[7]  D. Kohane,et al.  Self-assembled gemcitabine-gadolinium nanoparticles for magnetic resonance imaging and cancer therapy. , 2016, Acta biomaterialia.

[8]  Xiaohua Huang,et al.  Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. , 2006, Journal of the American Chemical Society.

[9]  J. Spadavecchia,et al.  The amphiphilic hydrophobin Vmh2 plays a key role in one step synthesis of hybrid protein-gold nanoparticles. , 2015, Colloids and surfaces. B, Biointerfaces.

[10]  S. Corti,et al.  Therapeutic applications of the cell-penetrating HIV-1 Tat peptide. , 2015, Drug Discovery Today.

[11]  M. Shehata.  Regulation of the epithelial sodium channel [ENaC] in kidneys of salt-sensitive Dahl rats: Insights on alternative splicing , 2009, International archives of medicine.

[12]  J. Spadavecchia,et al.  Arsenate reductase from Thermus thermophilus conjugated to polyethylene glycol-stabilized gold nanospheres allow trace sensing and speciation of arsenic ions , 2016, Journal of The Royal Society Interface.

[13]  Z. Qian,et al.  The in vitro and in vivo toxicity of gold nanoparticles , 2017 .

[14]  V. Rotello,et al.  Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. , 2006, Journal of the American Chemical Society.

[15]  D. Hirst,et al.  Gold nanoparticles as novel agents for cancer therapy. , 2012, The British journal of radiology.

[16]  V. Diculescu,et al.  In situ evaluation of gemcitabine-DNA interaction using a DNA-electrochemical biosensor. , 2014, Bioelectrochemistry.

[17]  F. Kashanchi,et al.  Cell Cycle-Regulated Transcription by the Human Immunodeficiency Virus Type 1 Tat Transactivator , 2000, Journal of Virology.

[18]  D. Jans,et al.  The HIV‐1 Tat Transactivator Protein: a Therapeutic Target? , 2003, IUBMB life.

[19]  David M. Shaw,et al.  Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter? , 2016, Sci. Eng. Ethics.

[20]  Shuming Nie,et al.  Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. , 2013, ACS nano.

[21]  Clemens Burda,et al.  The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. , 2012, Chemical Society reviews.

[22]  Shiladitya Sengupta,et al.  Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells , 2012, BMC Cancer.

[23]  Adriele Prina-Mello,et al.  Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies , 2016, International journal of nanomedicine.

[24]  R. Rabin,et al.  HIV-1 Tat protein mimicry of chemokines. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Xinpei Gao,et al.  The high yield synthesis and characterization of gold nanoparticles with superior stability and their catalytic activity , 2012 .

[26]  R. Doijad,et al.  Formulation and evaluation of gemcitabine-loaded solid lipid nanoparticles , 2015, Drug delivery.

[27]  H. Águas,et al.  Influence of the layer thickness in plasmonic gold nanoparticles produced by thermal evaporation , 2013, Scientific Reports.

[28]  Satoru Shoji,et al.  Ultrasmall all-optical plasmonic switch and its application to superresolution imaging , 2016, Scientific Reports.

[29]  H. Dosaka-akita,et al.  Fusion of HIV-1 Tat protein transduction domain to poly-lysine as a new DNA delivery tool , 2004, British Journal of Cancer.

[30]  A. Mitra,et al.  Recent developments in protein and peptide parenteral delivery approaches. , 2014, Therapeutic delivery.

[31]  R. Jain,et al.  Strategies for advancing cancer nanomedicine. , 2013, Nature materials.

[32]  J. Schellens,et al.  DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin. , 2003, Biochemical pharmacology.

[33]  Zachary D. Schultz,et al.  Online SERS detection and characterization of eight biologically-active peptides separated by capillary zone electrophoresis. , 2015, The Analyst.

[34]  D. Piwnica-Worms,et al.  Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. , 2000, Bioconjugate chemistry.

[35]  G. Belfort,et al.  Intermolecular forces between proteins and polymer films with relevance to filtration , 1997 .

[36]  S. Sung.  Peptide folding driven by Van der Waals interactions , 2015, Protein science : a publication of the Protein Society.

[37]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[38]  A. Georgakilas,et al.  Recent Advances in Cancer Therapy Based on Dual Mode Gold Nanoparticles , 2017, Cancers.

[39]  S. Choi,et al.  Mechanisms of drug release in nanotherapeutic delivery systems. , 2015, Chemical reviews.

[40]  P Ghaneh,et al.  Biology and management of pancreatic cancer , 2008, Postgraduate Medical Journal.

[41]  G. Peters,et al.  Synthesis and biological activity of a gemcitabine phosphoramidate prodrug. , 2007, Journal of medicinal chemistry.

[42]  Elodie Boisselier,et al.  Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.

[43]  Radha Kishan Motkuri,et al.  Recent developments in the synthesis, properties, and biomedical applications of core/shell superparamagnetic iron oxide nanoparticles with gold. , 2017, Biomaterials science.

[44]  S. Aggarwal,et al.  Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer , 2013, Cancer Nanotechnology.

[45]  A. Curtis,et al.  Diels Alder‐mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[46]  Jolanda Spadavecchia,et al.  Green extraction of endemic plants to synthesize gold nanoparticles for theranostic applications , 2017 .

[47]  J. Spadavecchia,et al.  Tuning the shape and size of hybrid gold nanoparticles by porphyrins using seed-mediated synthesis , 2014 .

[48]  Carlos Cuevas,et al.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.

[49]  A. Moshnikova,et al.  Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment , 2014, Scientific Reports.

[50]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[51]  Nathalie Dupont,et al.  Tunable Design of Gold(III)-Doxorubicin Complex-PEGylated Nanocarrier. The Golden Doxorubicin for Oncological Applications. , 2016, ACS applied materials & interfaces.

[52]  Dhiraj Kumar,et al.  Polyethylene glycol functionalized gold nanoparticles: the influence of capping density on stability in various media , 2011 .

[53]  I. Capek.  Polymer decorated gold nanoparticles in nanomedicine conjugates. , 2017, Advances in colloid and interface science.

[54]  Jason I. Herschkowitz,et al.  Surface-enhanced Raman scattering investigation of targeted delivery and controlled release of gemcitabine , 2017, International journal of nanomedicine.

[55]  Nadia Djaker,et al.  Taxanes Hybrid Nanovectors: From Design to Physico‐Chemical Evaluation of Docetaxel and Paclitaxel Gold (III)‐PEGylated Complex Nanocarriers , 2018 .

[56]  B. Peterlin,et al.  Control of RNA initiation and elongation at the HIV-1 promoter. , 1994, Annual review of biochemistry.

[57]  P. Kabouridis.  Biological applications of protein transduction technology. , 2003, Trends in biotechnology.

[58]  Yi Wang,et al.  Dual tumor-targeted poly(lactic-co-glycolic acid)–polyethylene glycol–folic acid nanoparticles: a novel biodegradable nanocarrier for secure and efficient antitumor drug delivery , 2017, International journal of nanomedicine.

[59]  S. Aștilean,et al.  Comparative toxicity evaluation of flower-shaped and spherical gold nanoparticles on human endothelial cells , 2015, Nanotechnology.

[60]  J. Neoptolemos,et al.  A new approach to managing intraductal papillary mucinous pancreatic neoplasms , 2007, Gut.